Latest Videos |view all videos
Mayo Clinic researcher Fergus J. Couch, Ph.D., discusses a study show that combined 77 common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer.
Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein.
Researchers at Mayo Clinic's campus in Florida have developed a mouse model that exhibits the features associated with the most common genetic form of ALS and frontotemporal dementia.
Andres Acosta, M.D., Ph.D, a Mayo Clinic gastroenterologist, discusses a recent study associating certain traits with obesity.
Joel M. Reid, Ph.D, presents The Pharmacokinetics Core: A Resource for Translational Science Innovation and Drug Development.
Dr. Murphy presents Instrumenting the Health Care Enterprise for Discovery Science